Study of Methylation Patterns in Colorectal Cancer
Author Information
Author(s): Nosho Katsuhiko, Irahara Natsumi, Shima Kaori, Kure Shoko, Kirkner Gregory J., Schernhammer Eva S., Hazra Aditi, Hunter David J., Quackenbush John, Spiegelman Donna, Giovannucci Edward L., Fuchs Charles S., Ogino Shuji
Primary Institution: Dana-Farber Cancer Institute and Harvard Medical School
Hypothesis
The study aims to evaluate the associations of the CpG island methylator phenotype (CIMP) with various clinical and molecular features in colorectal cancer using a large population-based sample.
Conclusion
CIMP-high is independently associated with clinical and key molecular features in colorectal cancer.
Supporting Evidence
- CIMP-high tumors are associated with older age and proximal tumor location.
- CIMP-high is linked to poor differentiation and BRAF mutation.
- KRAS mutation is associated with a random methylation pattern in CIMP-low tumors.
- The study utilized a large sample size to enhance the reliability of findings.
- CIMP-high status was determined using a validated panel of methylation markers.
Takeaway
This study looks at how certain markers in colorectal cancer can help doctors understand the disease better. It found that some markers are linked to more serious forms of cancer.
Methodology
DNA methylation at 16 CpG islands was quantified in 904 colorectal cancers using real-time PCR, and multivariate logistic regression was performed to analyze associations.
Potential Biases
Potential biases may arise from the selection of tumor samples and the retrospective nature of the analysis.
Limitations
The study may have confounding factors that could influence the associations observed.
Participant Demographics
The sample included 406 men and 498 women, with a mean age of 66.3 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website